glyburide has been researched along with Bright Disease in 1 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddi, AS | 1 |
| Oppermann, W | 1 |
| Patel, DG | 1 |
| Ehrenreich, T | 1 |
| Camerini-Davalos, RA | 1 |
1 other study available for glyburide and Bright Disease
| Article | Year |
|---|---|
Diabetic microangiopathy in KK mice. III. Effect of prolonged glyburide treatment on glomerulosclerosis.
Topics: Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Glomerulonephritis; Glomeruloscle | 1978 |